Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital – a five-year retrospective study

Bibliographic Details
Main Author: Gorgulho, A
Publication Date: 2020
Other Authors: Grilo, AM, Figueiredo, M, Selada, J
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.26/46540
Summary: Background: Our hospital experienced an outbreak of OXA-48-producing Enterobacteriaceae, triggering this study. We aimed to describe the population with carbapenemase-producing Enterobacteriaceae (CPE) in our hospital from 2014 to 2018, the phenotypic and genotypic characteristics of isolates, and strategies to stop the outbreak. Methods: We performed a retrospective study, including every patient with CPE species in a clinical sample. Epidemiology, risk factors, treatment and outcomes were gathered from medical records. Results: A total 113 patients were included, ranging from 5 in 2015 to 83 in 2018. In 2018 the number of CPE went from 4 in May to 20 in July. With the implemented measures, propagation stopped. Implantable devices were present in 36% of patients and open wounds in 34%. Antibiotics had been prescribed to 71% of patients in the prior 30 days and most of the patients had been hospitalized for more than 5 days prior to sample collection or had a hospital stay in the previous year.Klebsiella pneumoniae was the most common species (87%). OXA-48 (62%) and Klebsiella pneumoniae-carbapenemase (KPC) (15%) were the most common carbapenemases, with OXA-48 being implicated in the 2018 outbreak. The case fatality rate at 30 days was 32%. Combination therapy resulted in less mortality. Conclusions: While KPC is the most common carbapenemase in Europe and Portugal, we experienced an important OXA-48 outbreak. Surveillance should be in place as these isolates are probably spreading. Effective communication, multidisciplinary team work and proper infection control measures are some of the best strategies during outbreaks.
id RCAP_9a395458fa14bcba99b735d51ff35f76
oai_identifier_str oai:comum.rcaap.pt:10400.26/46540
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital – a five-year retrospective studyInfecções por EnterobacteriaceaeEnterobacteriáceas Resistentes a CarbapenémicosCarbapenémicosEnterobacteriaceae InfectionsCarbapenem-Resistant EnterobacteriaceaeCarbapenemsBackground: Our hospital experienced an outbreak of OXA-48-producing Enterobacteriaceae, triggering this study. We aimed to describe the population with carbapenemase-producing Enterobacteriaceae (CPE) in our hospital from 2014 to 2018, the phenotypic and genotypic characteristics of isolates, and strategies to stop the outbreak. Methods: We performed a retrospective study, including every patient with CPE species in a clinical sample. Epidemiology, risk factors, treatment and outcomes were gathered from medical records. Results: A total 113 patients were included, ranging from 5 in 2015 to 83 in 2018. In 2018 the number of CPE went from 4 in May to 20 in July. With the implemented measures, propagation stopped. Implantable devices were present in 36% of patients and open wounds in 34%. Antibiotics had been prescribed to 71% of patients in the prior 30 days and most of the patients had been hospitalized for more than 5 days prior to sample collection or had a hospital stay in the previous year.Klebsiella pneumoniae was the most common species (87%). OXA-48 (62%) and Klebsiella pneumoniae-carbapenemase (KPC) (15%) were the most common carbapenemases, with OXA-48 being implicated in the 2018 outbreak. The case fatality rate at 30 days was 32%. Combination therapy resulted in less mortality. Conclusions: While KPC is the most common carbapenemase in Europe and Portugal, we experienced an important OXA-48 outbreak. Surveillance should be in place as these isolates are probably spreading. Effective communication, multidisciplinary team work and proper infection control measures are some of the best strategies during outbreaks.Repositório ComumGorgulho, AGrilo, AMFigueiredo, MSelada, J2023-09-14T21:59:08Z20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.26/46540eng10.18683/germs.2020.1190info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-05-10T10:10:15Zoai:comum.rcaap.pt:10400.26/46540Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T07:07:34.490101Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital – a five-year retrospective study
title Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital – a five-year retrospective study
spellingShingle Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital – a five-year retrospective study
Gorgulho, A
Infecções por Enterobacteriaceae
Enterobacteriáceas Resistentes a Carbapenémicos
Carbapenémicos
Enterobacteriaceae Infections
Carbapenem-Resistant Enterobacteriaceae
Carbapenems
title_short Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital – a five-year retrospective study
title_full Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital – a five-year retrospective study
title_fullStr Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital – a five-year retrospective study
title_full_unstemmed Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital – a five-year retrospective study
title_sort Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital – a five-year retrospective study
author Gorgulho, A
author_facet Gorgulho, A
Grilo, AM
Figueiredo, M
Selada, J
author_role author
author2 Grilo, AM
Figueiredo, M
Selada, J
author2_role author
author
author
dc.contributor.none.fl_str_mv Repositório Comum
dc.contributor.author.fl_str_mv Gorgulho, A
Grilo, AM
Figueiredo, M
Selada, J
dc.subject.por.fl_str_mv Infecções por Enterobacteriaceae
Enterobacteriáceas Resistentes a Carbapenémicos
Carbapenémicos
Enterobacteriaceae Infections
Carbapenem-Resistant Enterobacteriaceae
Carbapenems
topic Infecções por Enterobacteriaceae
Enterobacteriáceas Resistentes a Carbapenémicos
Carbapenémicos
Enterobacteriaceae Infections
Carbapenem-Resistant Enterobacteriaceae
Carbapenems
description Background: Our hospital experienced an outbreak of OXA-48-producing Enterobacteriaceae, triggering this study. We aimed to describe the population with carbapenemase-producing Enterobacteriaceae (CPE) in our hospital from 2014 to 2018, the phenotypic and genotypic characteristics of isolates, and strategies to stop the outbreak. Methods: We performed a retrospective study, including every patient with CPE species in a clinical sample. Epidemiology, risk factors, treatment and outcomes were gathered from medical records. Results: A total 113 patients were included, ranging from 5 in 2015 to 83 in 2018. In 2018 the number of CPE went from 4 in May to 20 in July. With the implemented measures, propagation stopped. Implantable devices were present in 36% of patients and open wounds in 34%. Antibiotics had been prescribed to 71% of patients in the prior 30 days and most of the patients had been hospitalized for more than 5 days prior to sample collection or had a hospital stay in the previous year.Klebsiella pneumoniae was the most common species (87%). OXA-48 (62%) and Klebsiella pneumoniae-carbapenemase (KPC) (15%) were the most common carbapenemases, with OXA-48 being implicated in the 2018 outbreak. The case fatality rate at 30 days was 32%. Combination therapy resulted in less mortality. Conclusions: While KPC is the most common carbapenemase in Europe and Portugal, we experienced an important OXA-48 outbreak. Surveillance should be in place as these isolates are probably spreading. Effective communication, multidisciplinary team work and proper infection control measures are some of the best strategies during outbreaks.
publishDate 2020
dc.date.none.fl_str_mv 2020
2020-01-01T00:00:00Z
2023-09-14T21:59:08Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.26/46540
url http://hdl.handle.net/10400.26/46540
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.18683/germs.2020.1190
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833602893557530624